• 1
    Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 22312235.
  • 2
    Alter MJ. Epidemiology of hepatitis C in the West. Sem Liver Dis 1995; 15: 514.
  • 3
    Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991; 325: 13251329.
  • 4
    Koretz RL, Brezina M, Polito AJ, Quan S, Wilber J, Dinello R, Gitnick G. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis. Hepatology 1993; 17: 361365.
  • 5
    McQuillan G, Alter M, Moyer L, Lambert S, Margolis H. A population based serologic study of hepatitis C virus infection in the United States [Abstract]. Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease, Rome; 1996: 8A.
  • 6
    Alter MJ, Gerety RJ, Smallwood L, Sampliner RE, Tabor E, Deinhardt F, Frosner G, et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban United States population. J Infect Dis 1982; 145: 886893.
  • 7
    Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E, Hadler SC, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989; 262: 12011205.
  • 8
    Alter MJ. Residual risk of transfusion-associated hepatitis. NIH Consensus Development Conference on Infectious Disease Testing for Blood Transfusions, Bethesda; 1995: 2327.
  • 9
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 16851690.
  • 10
    Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Pub Health 1996; 86: 655661.
  • 11
    Centers for Disease Control and Prevention. Risk of acquiring hepatitis C for health care workers and recommendations for prophylaxis and follow-up after occupational exposure. Hepatitis Surveillance Report No. 56. Atlanta; 1995: 36.
  • 12
    Polish LB, Tong MJ, Co RL, Coleman PG, Alter MJ. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993; 21: 196200.
  • 13
    Puro V, Petrosillo N, Ippolito G Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 1995; 23: 273277.
  • 14
    Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T, et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16: 11091114.
  • 15
    Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva [Letter]. Scand J Infect Dis 1993; 25: 270271.
  • 16
    Moyer LA, Alter MJ. Hepatitis C virus in the hemodialysis setting: a review with recommendations for control. Sem Dial 1994; 7: 124127.
  • 17
    Esteban JI, Gomez J, Martell M, Cabot B, Quer J, Camps J, Gonzalez A, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1995; 334: 555560.
  • 18
    Conry-Cantilena C, Vanraden M, Gibble J, Melpoler J, Shakil AO, Viladomiu L, Cheung L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 16911696.
  • 19
    Mast EE, Alter MJ. Hepatitis C. Sem Fed Infect Dis 1997; 8: 17.
  • 20
    Centers for Disease Control. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991; 40 (RR-4): 117.
  • 21
    Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles. JAMA 1997; 277: 5362.